Therapeutic cell carriers: a potential road to cure glioma

References

• Stupp R, Mason WP, Van Den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352(10):987-96
   PubMed Web of Science ®Google Scholar
• Bloch O, Han SJ, Cha S, et al. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg 2012;117(6):1032-8
   PubMed Web of Science ®Google Scholar
• Grossman SA, Ye X, Piantadosi S, et al. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin Cancer Res 2010;16(8):2443-9
   PubMed Web of Science ®Google Scholar
• Lesniak MS. Gene therapy for malignant glioma. Expert Rev Neurother 2006;6(4):479-88
   Google Scholar
• Tobias A, Ahmed A, Moon K-S, Lesniak MS. The art of gene therapy for glioma: a review of the challenging road to the bedside. J Neurol Neurosurg Psychiatr 2013;84(2):213-22
   PubMed Web of Science ®Google Scholar
• Allhenn D, Boushehri MAS, Lamprecht A. Drug delivery strategies for the treatment of malignant gliomas. Int J Pharm 2012;436(1-2):299-310
   PubMedGoogle Scholar
• Debinski W, Tatter SB. Convection-enhanced delivery for the treatment of brain tumors. Expert Rev Neurother 2009;9(10):1519-27
   Google Scholar
• Willmon C, Harrington K, Kottke T, et al. Cell carriers for oncolytic viruses: fed Ex for cancer therapy. Mol Ther 2009;17(10):1667-76
   PubMed Web of Science ®Google Scholar
• Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000;97(23):12846-51
   PubMed Web of Science ®Google Scholar
• Murphy AM, Rabkin SD. Current status of gene therapy for brain tumors. Transl Res 2013;161(4):339-54
   Google Scholar
• Frank RT, Najbauer J, Aboody KS. Concise Review: stem cells as an emerging platform for antibody therapy of cancer. Stem Cells 2010;28(11):2084-7
   PubMed Web of Science ®Google Scholar
• Roger M, Clavreul A, Venier-Julienne MC, et al. The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy. Biomaterials 2011;32(8):2106-16
   PubMed Web of Science ®Google Scholar
• Temple S. The development of neural stem cells. Nature 2001;414(6859):112-17
   PubMed Web of Science ®Google Scholar
• Kranzler J, Tyler MA, Sonabend AM, et al. Stem cells as delivery vehicles for oncolytic adenoviral virotherapy. Curr Gene Ther 2009;9(5):389-95
   PubMed Web of Science ®Google Scholar
• Ahmed AU, Alexiades NG, Lesniak MS. The use of neural stem cells in cancer gene therapy: predicting the path to the clinic. Curr Opin Mol Ther 2010;12(5):546-52
   PubMed Web of Science ®Google Scholar
• Müller FJ, Snyder EY, Loring JF. Gene therapy: can neural stem cells deliver? Nat Rev Neurosci 2006;7(1):75-84
   PubMed Web of Science ®Google Scholar
• An JH, Lee SY, Jeon JY, et al. Identification of gliotropic factors that induce human stem cell migration to malignant tumor. J Proteome Res 2009;8(6):2873-81
   PubMed Web of Science ®Google Scholar
• Pluchino S, Quattrini A, Brambilla E, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003;422(6933):688-94
   PubMed Web of Science ®Google Scholar
• Pluchino S, Gritti A, Blezer E, et al. Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates. Ann Neurol 2009;66(3):343-54
   PubMed Web of Science ®Google Scholar
• Wollmann G, Ozduman K, van den Pol AN. Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates. Cancer J 2012;18(1):69-81
   PubMed Web of Science ®Google Scholar
• Tyler MA, Ulasov IV, Sonabend AM, et al. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Gene Ther 2009;16(2):262-78
   PubMed Web of Science ®Google Scholar
• Ulasov IV, Rivera AA, Sonabend AM, et al. Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy. Cancer Biol Ther 2007;6(5):679-85
   PubMed Web of Science ®Google Scholar
• Thaci B, Ahmed AU, Ulasov IV, et al. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model. Cancer Gene Ther 2012;19(6):431-42
   PubMed Web of Science ®Google Scholar
• Cheng Y, Morshed R, Cheng SH, et al. Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapy. Small 2013;9(24):4123-9
   PubMed Web of Science ®Google Scholar
• Germano IM, Uzzaman M, Benveniste RJ, et al. Apoptosis in human glioblastoma cells produced using embryonic stem cell-derived astrocytes expressing tumor necrosis factor-related apoptosis-inducing ligand. J Neurosurg 2006;105(1):88-95
   Google Scholar
• Panner A, James CD, Berger MS, Pieper RO. mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol Cell Biol 2005;25(20):8809-23
   PubMed Web of Science ®Google Scholar
• Ehtesham M, Kabos P, Gutierrez MAR, et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 2002;62(24):7170-4
   PubMed Web of Science ®Google Scholar
• Danks MK, Yoon KJ, Bush RA, et al. Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Cancer Res 2007;67(1):22-5
   PubMed Web of Science ®Google Scholar
• Metz MZ, Gutova M, Lacey SF, et al. Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use. Stem Cells Transl Med 2013;2(12):983-92
   PubMed Web of Science ®Google Scholar
• Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2009;6(2):e1000029
   PubMed Web of Science ®Google Scholar
• A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas. Available from: www.clinicaltrials.gov/ct2/results?term=NCT01172964&Search=Search
   Google Scholar
• Shah K. Mesenchymal stem cells engineered for cancer therapy. Adv Drug Deliv Rev 2012;64(8):739-48
   PubMed Web of Science ®Google Scholar
• Hu YL, Fu YH, Tabata Y, Gao JQ. Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy. J Control Release 2010;147(2):154-62
   PubMed Web of Science ®Google Scholar
• Jones BJ, McTaggart SJ. Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp Hematol 2008;36(6):733-41
   Google Scholar
• Nakamizo A, Marini F, Amano T, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005;65(8):3307-18
   PubMed Web of Science ®Google Scholar
• Kim SM, Lim JY, Park SI, et al. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res 2008;68(23):9614-23
   PubMed Web of Science ®Google Scholar
• Hu YL, Huang B, Zhang TY, et al. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection. Mol Pharm 2012;9(9):2698-709
   Google Scholar
• Shah K. Stem cell therapeutics for cancer. John Wiley and Sons; NY, USA: 2013
   Google Scholar
• Beckermann BM, Kallifatidis G, Groth A, et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer 2008;99(4):622-31
   PubMed Web of Science ®Google Scholar
• Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007;25(11):2739-49
   PubMed Web of Science ®Google Scholar
• Huang J, Zhang Z, Guo J, et al. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res 2010;106(11):1753-62
   PubMed Web of Science ®Google Scholar
• Komarova S, Kawakami Y, Stoff-Khalili MA, et al. Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther 2006;5(3):755-66
   PubMed Web of Science ®Google Scholar
• Sonabend AM, Ulasov IV, Tyler MA, et al. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells 2008;26(3):831-41
   PubMed Web of Science ®Google Scholar
• Jiang H, Gomez-Manzano C, Aoki H, et al. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst 2007;99(18):1410-14
   PubMed Web of Science ®Google Scholar
• Yong RL, Shinojima N, Fueyo J, et al. Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Cancer Res 2009;69(23):8932-40
   PubMed Web of Science ®Google Scholar
• García-Castro J, Alemany R, Cascalló M, et al. Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study. Cancer Gene Ther 2010;17(7):476-83
   PubMed Web of Science ®Google Scholar
• Ponte AL, Marais E, Gallay N, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007;25(7):1737-45
   PubMed Web of Science ®Google Scholar
• Roger M, Clavreul A, Huynh NT, et al. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy. Int J Pharm 2012;423(1):63-8
   PubMed Web of Science ®Google Scholar
• Dai T, Yang E, Sun Y, et al. Preparation and drug release mechanism of CTS-TAX-NP-MSCs drug delivery system. Int J Pharm 2013;456(1):186-94
   PubMed Web of Science ®Google Scholar
• Chan J, O’Donoghue K, de la Fuente J, et al. Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 2005;23(1):93-102
   Web of Science ®Google Scholar
• Horwitz EM, Gordon PL, Koo WKK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 2002;99(13):8932-7
   PubMed Web of Science ®Google Scholar
• Menon LG, Kelly K, Yang HW, et al. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells 2009;27(9):2320-30
   PubMed Web of Science ®Google Scholar
• Balyasnikova IV, Prasol MS, Ferguson SD, et al. Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors. Mol Ther 2014;22(1):140-8
   PubMed Web of Science ®Google Scholar
• Kanehira M, Xin H, Hoshino K, et al. Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells. Cancer Gene Ther 2007;14(11):894-903
   Google Scholar
• Nakamura K, Ito Y, Kawano Y, et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004;11(14):1155-64
   PubMed Web of Science ®Google Scholar
• Fei S, Qi X, Kedong S, et al. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model. J Cancer Res Clin Oncol 2012;138(2):347-57
   PubMed Web of Science ®Google Scholar
• Elzaouk L, Moelling K, Pavlovic J. Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model. Exp Dermatol 2006;15(11):865-74
   PubMed Web of Science ®Google Scholar
• Xin H, Kanehira M, Mizuguchi H, et al. Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. Stem Cells 2007;25(7):1618-26
   PubMed Web of Science ®Google Scholar
• Choi SA, Lee JY, Wang K-C, et al. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas. Eur J Cancer 2012;48(1):129-37
   PubMed Web of Science ®Google Scholar
• Balyasnikova IV, Ferguson SD, Sengupta S, et al. Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully Inhibit the growth of human xenograft malignant glioma. PLoS ONE 2010;5(3):e9750
   PubMed Web of Science ®Google Scholar
• Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 2009;4(3):206-16
   PubMed Web of Science ®Google Scholar
• Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449(7162):557-63
   PubMed Web of Science ®Google Scholar
• Di Stasi A, Tey S-K, Dotti G, et al. Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med 2011;365(18):1673-83
   PubMed Web of Science ®Google Scholar
• Akimoto K, Kimura K, Nagano M, et al. Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem Cells Dev 2013;22(9):1370-86
   Google Scholar
• Shi M, Li J, Liao L, et al. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica 2007;92(7):897-904
   PubMed Web of Science ®Google Scholar
• Cheng Z, Ou L, Zhou X, et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 2008;16(3):571-9
   PubMed Web of Science ®Google Scholar
• Levy O, Zhao W, Mortensen LJ, et al. mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. Blood 2013 122(14):e23-32
   Google Scholar
• Sackstein R, Merzaban JS, Cain DW, et al. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 2008;14(2):181-7
   PubMed Web of Science ®Google Scholar
• Liu L, Eckert MA, Riazifar H, et al. From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? Stem Cells Int 2013;2013:435093
   PubMedGoogle Scholar
• Díaz-Coránguez M, Segovia J, López-Ornelas A, et al. Transmigration of neural stem cells across the blood brain barrier induced by glioma cells. PLoS One 2013;8(4):e60655
   Google Scholar
• Ahmed AU, Tyler MA, Thaci B, et al. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma. Mol Pharm 2011;8(5):1559-72
   PubMedGoogle Scholar
• Tabatabai G, Wick W, Weller M. Stem cell-mediated gene therapies for malignant gliomas: a promising targeted therapeutic approach? Discov Med 2011;11(61):529-36
   Google Scholar
• Varma NRS, Janic B, Iskander ASM, et al. Endothelial progenitor cells (EPCs) as gene carrier system for rat model of human glioma. PLoS One 2012;7(1):e30310
   PubMedGoogle Scholar
• Tabatabai G, Hasenbach K, Herrmann C, et al. Glioma tropism of lentivirally transduced hematopoietic progenitor cells. Int J Oncol 2010;36(6):1409-17
   Google Scholar
• Deng W, Jia J. Endothelial progenitor cells as cellular vehicles to deliver oncolytic virus therapies to metastatic tumors: the ‘Trojan horse’ approach. Med Hypotheses 2008;70(4):842-4
   Google Scholar
• Dudek AZ. Endothelial lineage cell as a vehicle for systemic delivery of cancer gene therapy. Transl Res 2010;156(3):136-46
   Google Scholar
• Alberti MO, Deshane JS, Chaplin DD, et al. A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism. Gene Ther 2013;20(7):733-41
   Google Scholar
• Coukos G, Makrigiannakis A, Kang EH, et al. Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer. Clin Cancer Res 1999;5(6):1523-37
   Google Scholar
• Lun XQ, Zhou H, Alain T, et al. Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin. Cancer Res 2007;67(18):8818-27
   PubMed Web of Science ®Google Scholar
• Kim SM, Woo JS, Jeong CH, et al. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma. Stem Cells Transl Med 2014;3(2):172-82
   Google Scholar
• Kim SM, Oh JH, Park SA, et al. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy. Stem Cells 2010;28(12):2217-28
   PubMed Web of Science ®Google Scholar
• Tobias AL, Thaci B, Auffinger B, et al. The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma. Stem Cells Transl Med 2013;2(9):655-66
   PubMed Web of Science ®Google Scholar
• Rowntree RK, McNeish JD. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery. Regen Med 2010;5(4):557-68
   Google Scholar
• Slettenaar VIF, Wilson JL. The chemokine network: a target in cancer biology? Adv Drug Deliv Rev 2006;58(8):962-74
   Google Scholar
• Ebert LM, Schaerli P, Moser B. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol 2005;42(7):799-809
   Google Scholar
• Auffinger B, Morshed R, Tobias A, et al. Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma? Oncotarget 2013;4(3):378-96
   PubMedGoogle Scholar
• Bos PD, Zhang XHF, Nadal C, et al. Genes that mediate breast cancer metastasis to the brain. Nature 2009;459(7249):1005-9
   PubMed Web of Science ®Google Scholar
• Kauer TM, Figueiredo JL, Hingtgen S, Shah K. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas. Nat Neurosci 2012;15(2):197-204
   Web of Science ®Google Scholar
• Mattis VB, Svendsen CN. Induced pluripotent stem cells: a new revolution for clinical neurology? Lancet Neurol 2011;10(4):383-94
   PubMed Web of Science ®Google Scholar
• Lee EX, Lam DH, Wu C, et al. Glioma gene therapy using induced pluripotent stem cell derived neural stem cells. Mol Pharm 2011;8(5):1515-24
   PubMedGoogle Scholar
• Yamanaka S. A fresh look at iPS cells. Cell 2009;137(1):13-17
   PubMed Web of Science ®Google Scholar
• Wykosky J, Gibo DM, Stanton C, Debinski W. Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy. Clin Cancer Res 2008;14(1):199-208
   PubMed Web of Science ®Google Scholar
• Bhirde A, Xie J, Swierczewska M, Chen X. Nanoparticles for cell labeling. Nanoscale 2011;3(1):142-53
   PubMed Web of Science ®Google Scholar
• Pham W, Xie J, Gore JC. Tracking the migration of dendritic cells by in vivo optical imaging. Neoplasia 2007;9(12):1130-7
   Google Scholar